Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin - Summary - MDSpire

Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

  • By

  • Guohua Qin

  • AiQiang Dong

  • Ning Wang

  • Xinfeng Liu

  • Yingying Zhang

  • Guoqiang Wang

  • Chenghui Lu

  • Jiao Li

  • Na Han

  • ZengHua Wang

  • Zengmei Si

  • Fengqi Li

  • Rui Wang

  • Congcong Wang

  • Xufu Wang

  • June 2, 2026

  • 0 min

Share

Objective:

To investigate the predictive value of serum cytokines for treatment response to initial radioactive iodine therapy (RAI) in patients with intermediate- or high-risk differentiated thyroid cancer (DTC) and to develop a novel nomogram model for this purpose.

Key Findings:
  • ROC curve of the nomogram model developed using the training cohort exhibited acceptable predictive performance.
Interpretation:

Remove this section.

Limitations:
  • Add relevant limitations from the source if available.
Conclusion:

Revise to reflect only the findings without unsupported implications.

Original Source(s)

Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin

  • by Guohua Qin, AiQiang Dong, Ning Wang, Xinfeng Liu, Yingying Zhang, Guoqiang Wang, Chenghui Lu, Jiao Li, Na Han, ZengHua Wang, Zengmei Si, Fengqi Li, Rui Wang, Congcong Wang, Xufu Wang

  • June 2, 2026

Related Content

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

Clinical efficacy and safety of porcine fibrin sealant in video-assisted thoracoscopic surgery lobectomy for lung cancer

Case Report: Intramedullary solitary fibrous tumor at the C7-T1 level diagnosed by STAT6 and treated with maximal safe resection